Tylor R Lewis, Sebastien Phan, Carson M Castillo, Keun-Young Kim, Mark H Ellisman, Vadim Y Arshavsky
{"title":"Loss of Usher II Proteins in Mice Does Not Affect Photoreceptor Ultrastructure.","authors":"Tylor R Lewis, Sebastien Phan, Carson M Castillo, Keun-Young Kim, Mark H Ellisman, Vadim Y Arshavsky","doi":"10.1007/978-3-031-76550-6_29","DOIUrl":null,"url":null,"abstract":"<p><p>Usher syndrome is characterized by both vision and hearing loss. Mutations in three genes, USH2A, ADGRV1, and WHRN, lead to Usher syndrome Type II, in which the onset of vision loss usually takes place after puberty. Mouse models of Usher syndrome Type II have an incredibly mild retinal phenotype that typically begins after ~1-2 years of age and, therefore, do not fully represent the pathology in human patients. Both USH2A (also known as Usherin) and ADGRV1 (also known as USH2C or GPR98) are transmembrane proteins containing large extracellular domains. In this study, we questioned whether the relatively mild phenotype of USH2A and ADGRV1 mutant mouse models may arise from a functional redundancy between these two proteins. We generated a double knockout (Ush2a<sup>-/-</sup>; Adgrv1<sup>-/-</sup>) mouse and analyzed its retinal ultrastructure. We found no notable morphological defects in photoreceptor inner segments, connecting the cilia and outer segments of these mice at 1 month of age. These data indicate that functional redundancy between USH2A and ADGRV1 does not underlie the mild and late-onset retinal pathology observed in mice as compared to the aggressive nature of vision loss observed in corresponding human patients.</p>","PeriodicalId":7270,"journal":{"name":"Advances in experimental medicine and biology","volume":"1468 ","pages":"177-181"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in experimental medicine and biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/978-3-031-76550-6_29","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
Loss of Usher II Proteins in Mice Does Not Affect Photoreceptor Ultrastructure.
Usher syndrome is characterized by both vision and hearing loss. Mutations in three genes, USH2A, ADGRV1, and WHRN, lead to Usher syndrome Type II, in which the onset of vision loss usually takes place after puberty. Mouse models of Usher syndrome Type II have an incredibly mild retinal phenotype that typically begins after ~1-2 years of age and, therefore, do not fully represent the pathology in human patients. Both USH2A (also known as Usherin) and ADGRV1 (also known as USH2C or GPR98) are transmembrane proteins containing large extracellular domains. In this study, we questioned whether the relatively mild phenotype of USH2A and ADGRV1 mutant mouse models may arise from a functional redundancy between these two proteins. We generated a double knockout (Ush2a-/-; Adgrv1-/-) mouse and analyzed its retinal ultrastructure. We found no notable morphological defects in photoreceptor inner segments, connecting the cilia and outer segments of these mice at 1 month of age. These data indicate that functional redundancy between USH2A and ADGRV1 does not underlie the mild and late-onset retinal pathology observed in mice as compared to the aggressive nature of vision loss observed in corresponding human patients.
期刊介绍:
Advances in Experimental Medicine and Biology provides a platform for scientific contributions in the main disciplines of the biomedicine and the life sciences. This series publishes thematic volumes on contemporary research in the areas of microbiology, immunology, neurosciences, biochemistry, biomedical engineering, genetics, physiology, and cancer research. Covering emerging topics and techniques in basic and clinical science, it brings together clinicians and researchers from various fields.